this study indicates that combining nonsteroidal anti-inflammatory drugs which inhibit different sites of the inflammatory response ( i.e. , benoxaprofen , an inhibitor of the directional migration of monocytes , with aspirin , a potent inhibitor of prostaglandin synthesis ) may be advantageous in treating patients with rheumatoid arthritis .
C0004057
aspirin
C0003873
rheumatoid arthritis